Axsome Therapeutics (AXSM) Asset Utilization Ratio (2022 - 2026)

Axsome Therapeutics has reported Asset Utilization Ratio for 5 years, with the latest figure at 1.01 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 87.33% year-over-year to 1.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.01 (up 87.33% YoY) and the FY2025 annual result came in at 1.01, up 52.18% from the prior year.
• Asset Utilization Ratio grew to 1.01 in Q1 2026 per AXSM's latest filing, from 0.94 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 1.01 in Q1 2026 and troughed at 0.1 in Q3 2022.
• A 5-year average of 0.51 and a median of 0.47 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio jumped 273.01% in 2023, then gained 4.0% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.15 in 2022, then jumped by 204.91% to 0.46 in 2023, then advanced by 4.0% to 0.47 in 2024, then surged by 98.51% to 0.94 in 2025, then gained by 7.42% to 1.01 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.01, 0.94, and 0.68 for Q1 2026, Q4 2025, and Q3 2025 respectively.